1. Home
  2. RNAZ vs FRGT Comparison

RNAZ vs FRGT Comparison

Compare RNAZ & FRGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNAZ
  • FRGT
  • Stock Information
  • Founded
  • RNAZ 2016
  • FRGT 2015
  • Country
  • RNAZ United States
  • FRGT Mexico
  • Employees
  • RNAZ N/A
  • FRGT N/A
  • Industry
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • FRGT Professional Services
  • Sector
  • RNAZ Health Care
  • FRGT Consumer Discretionary
  • Exchange
  • RNAZ Nasdaq
  • FRGT Nasdaq
  • Market Cap
  • RNAZ 6.1M
  • FRGT 5.3M
  • IPO Year
  • RNAZ 2021
  • FRGT N/A
  • Fundamental
  • Price
  • RNAZ $7.97
  • FRGT $1.87
  • Analyst Decision
  • RNAZ Strong Buy
  • FRGT
  • Analyst Count
  • RNAZ 1
  • FRGT 0
  • Target Price
  • RNAZ $280.00
  • FRGT N/A
  • AVG Volume (30 Days)
  • RNAZ 32.8K
  • FRGT 148.0K
  • Earning Date
  • RNAZ 08-13-2025
  • FRGT 08-16-2025
  • Dividend Yield
  • RNAZ N/A
  • FRGT N/A
  • EPS Growth
  • RNAZ N/A
  • FRGT N/A
  • EPS
  • RNAZ N/A
  • FRGT N/A
  • Revenue
  • RNAZ N/A
  • FRGT $13,541,802.00
  • Revenue This Year
  • RNAZ N/A
  • FRGT $371.03
  • Revenue Next Year
  • RNAZ N/A
  • FRGT N/A
  • P/E Ratio
  • RNAZ N/A
  • FRGT N/A
  • Revenue Growth
  • RNAZ N/A
  • FRGT N/A
  • 52 Week Low
  • RNAZ $6.15
  • FRGT $1.54
  • 52 Week High
  • RNAZ $970.20
  • FRGT $36.00
  • Technical
  • Relative Strength Index (RSI)
  • RNAZ 47.04
  • FRGT 35.17
  • Support Level
  • RNAZ $7.32
  • FRGT $1.73
  • Resistance Level
  • RNAZ $8.48
  • FRGT $2.16
  • Average True Range (ATR)
  • RNAZ 0.58
  • FRGT 0.16
  • MACD
  • RNAZ 0.41
  • FRGT 0.04
  • Stochastic Oscillator
  • RNAZ 70.77
  • FRGT 31.34

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

About FRGT Freight Technologies Inc.

Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.

Share on Social Networks: